Lee Su Jin, Thien Quach Cung Hoa, Jung Kyung-Ho, Paik Jin-Young, Lee Jin Hee, Park Jin Won, Lee Kyung-Han
Department of Nuclear Medicine, Ajou University School of Medicine, Suwon, Korea; and.
Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Nucl Med. 2014 Oct;55(10):1699-705. doi: 10.2967/jnumed.114.139428. Epub 2014 Sep 11.
For (18)F-FDG PET to be widely used to monitor atherosclerosis progression and therapeutic response, it is crucial to better understand how macrophage glucose metabolism is influenced by the atherosclerotic microenvironment and to elucidate the molecular mechanisms of this response. Oxidized low-density lipoprotein (oxLDL) is a key player in atherosclerotic inflammation that promotes macrophage recruitment, activation, and foam cell formation. We thus explored the effect of oxLDL on macrophage (18)F-FDG uptake and investigated the underlying molecular mechanism including the roles of hypoxia-inducible factor-1α (HIF-1α) and reactive oxygen species (ROS).
RAW264.7 macrophages were stimulated with native LDL, oxLDL, or lipopolysaccharide. Cells were assessed for (18)F-FDG uptake, lactate production, membrane glucose transporter 1 (GLUT1) expression, and hexokinase activity. ROS generation, Nox expression, and HIF-1α activity were also measured.
oxLDL (20 μg/mL) induced a 17.5 ± 1.7-fold increase in macrophage (18)F-FDG uptake by 24 h, which was accompanied by increased lactate production, membrane GLUT1 expression, and hexokinase activity. oxLDL-stimulated (18)F-FDG uptake was completely blocked by inhibitors of Src or phosphoinositide 3-kinase. ROS generation was increased to 262.4% ± 17.9% of controls by oxLDL, and N-acetyl-l-cysteine completely abrogated both oxLDL-induced ROS production and (18)F-FDG uptake. oxLDL increased Nox2 expression, and nicotinamide adenine dinucleotide phosphate oxidase inhibition totally blocked increased ROS generation and (18)F-FDG uptake by oxLDL. Finally, there was a clear ROS-dependent increase of HIF-1α accumulation by oxLDL, and silencing of HIF-1α completely abolished the metabolic effect of oxLDL.
oxLDL is a strong stimulator of macrophage (18)F-FDG uptake and glycolysis through upregulation of GLUT1 and hexokinase. This metabolic response is mediated by Nox2-dependent ROS generation that promotes HIF-1α activation.
为了使(18)F - FDG PET广泛用于监测动脉粥样硬化进展和治疗反应,更深入了解巨噬细胞葡萄糖代谢如何受动脉粥样硬化微环境影响并阐明这种反应的分子机制至关重要。氧化型低密度脂蛋白(oxLDL)是动脉粥样硬化炎症中的关键因素,可促进巨噬细胞募集、激活和泡沫细胞形成。因此,我们探讨了oxLDL对巨噬细胞(18)F - FDG摄取的影响,并研究了其潜在分子机制,包括缺氧诱导因子-1α(HIF - 1α)和活性氧(ROS)的作用。
用天然低密度脂蛋白、oxLDL或脂多糖刺激RAW264.7巨噬细胞。评估细胞的(18)F - FDG摄取、乳酸生成、膜葡萄糖转运蛋白1(GLUT1)表达和己糖激酶活性。还测量了ROS生成、Nox表达和HIF - 1α活性。
oxLDL(20μg/mL)在24小时内使巨噬细胞(18)F - FDG摄取增加了17.5±1.7倍,同时伴有乳酸生成增加、膜GLUT1表达增加和己糖激酶活性增加。oxLDL刺激的(18)F - FDG摄取被Src或磷酸肌醇3激酶抑制剂完全阻断。oxLDL使ROS生成增加至对照组的262.4%±17.9%,N - 乙酰 - L - 半胱氨酸完全消除了oxLDL诱导的ROS生成和(18)F - FDG摄取。oxLDL增加了Nox2表达,烟酰胺腺嘌呤二核苷酸磷酸氧化酶抑制完全阻断了oxLDL诱导的ROS生成增加和(18)F - FDG摄取。最后,oxLDL导致HIF - 1α积累明显依赖于ROS增加,HIF - 1α沉默完全消除了oxLDL的代谢效应。
oxLDL通过上调GLUT1和己糖激酶,是巨噬细胞(18)F - FDG摄取和糖酵解的强烈刺激剂。这种代谢反应由促进HIF - 1α激活的Nox2依赖性ROS生成介导。